ONCOLOGY

It includes two updated recommendations.

High positive predictive value, detection rate, reproducibility.

Trial was terminated early because of futility.

New trial results presented at the European Association of Urology Congress 2019.

Research carried out at Frimley Park Hospital.

The study led by the University of Cambridge was presented at the European Association of Urology 2019 congress last weekend.

Real-life data show a higher risk for thrombocytopenia and spinal cord compression than was found in the ALSYMPCA trial.

Pre-operative screening for high neuroticism could prepare patients for more adverse events after radical prostatectomy.

Patients receiving androgen deprivation therapy should be monitored for mental health issues.

The finding may call into question the general applicability of Nobel Prize winning hormonal prostate treatment.

Data from the phase 3 NRG Oncology RTOG 0521 trial.

EBRT tied to more sexual dysfunction, urinary and bowel symptoms.

RT improves 3-year biochemical progression and FFS in unselected patients.

Modest benefit with use for 5 or more years postdiagnosis.